Found 188 with Last Name = 'van gaalen' and Initial = 'm' 
Affinity DataKi: 0.0300nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0300nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0400nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.0800nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.260nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 0.810nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Affinity DataKi: <1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Affinity DataKi: <1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 1.10nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cell membranes after 60 mins by TopCount microplate scintillation counti...More data for this Ligand-Target Pair
Affinity DataKi: 1.20nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cell membranes after 60 mins by TopCount microplate scintillation counti...More data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cell membranes after 60 mins by TopCount microplate scintillation counti...More data for this Ligand-Target Pair
Affinity DataKi: 1.70nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cell membranes after 60 mins by TopCount microplate scintillation counti...More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cell membranes after 60 mins by TopCount microplate scintillation counti...More data for this Ligand-Target Pair
Affinity DataKi: 2.10nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 3.80nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 3.90nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by scintillation countingMore data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cell membranes after 60 mins by TopCount microplate scintillation counti...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nM ΔG°: -47.1kJ/molepH: 7.4 T: 2°CAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)). The incu...More data for this Ligand-Target Pair
